SearchDictionaryMobileLogin

Echinococcosis (Hydatid Cysts)

1403  relevant articles (85 outcomes, 107 trials/studies) found for this Disease

Description: An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.

Also Known As:
Hydatid Cysts; Hydatid Cyst; Hydatidosis; Cyst, Hydatid; Echinococcoses; Hydatidoses; Cysts, Hydatid

Relationship Network

Disease Context: Research Results

Related Diseases

1. Cysts
2. Echinococcosis (Hydatid Cysts)
3. Infection
4. Cysticercosis
5. Body Weight (Weight, Body)

Experts

1. Craig, P S: 5 articles (05/2007 - 06/2000)
2. Teggi, A: 5 articles (12/2005 - 11/2000)
3. Riganò, R: 5 articles (12/2005 - 11/2000)
4. Profumo, E: 5 articles (12/2005 - 11/2000)
5. Siracusano, A: 5 articles (12/2005 - 11/2000)
6. Margutti, P: 5 articles (12/2005 - 11/2000)
7. Ortona, E: 5 articles (12/2005 - 11/2000)
8. Gottstein, Bruno: 4 articles (05/2008 - 08/2002)
9. Buttari, B: 4 articles (12/2005 - 11/2000)
10. Moreno, M J: 4 articles (06/2002 - 06/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Echinococcosis:
1. Albendazole (Albenza)FDA Link
2. Mebendazole (Vermin)FDA Link
3. AntigensIBA
4. Praziquantel (Biltricide)FDA Link
5. benzimidazoleIBA
6. AntibodiesIBA
7. Immunoglobulin G (IgG)IBA
8. Interferon Type II (Interferon, gamma)IBA
9. Ivermectin (Mectizan)FDA Link
10. CytokinesIBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
07/01/1998 - "Surgical removal of macroscopically detectable metacestode tissue followed by postoperative chemotherapy according to established human protocols resulted in complete clinical remission and immediate normalization of hyperglobulinemia in a dog with alveolar echinococcosis (AE)"
03/01/1994 - "The efficacy of long-term chemotherapy in nonresectable alveolar echinococcosis is debated, particularly because of the difficulty in defining therapeutic success"
06/01/2006 - "A serious public health problem caused by echinococcosis was evident in southern NHAR, typified by: a long diagnostic history for both AE and CE (7.5 years) compared with a shorter treatment history (4.7 years); a significant mortality rate (39%) caused by AE in one surveyed village, where patients had no previous access to treatment; family aggregation of CE and AE cases; a high proportion of both AE (62.5%) and CE (58%) in females; a high rate of recurrent surgery (30%) for CE demonstrated by surgical records; and frequent symptomatic recurrences (51%) because of discontinuous or sporadic access to chemotherapy for AE. The disease burden for both human AE and CE is thus very severe among these rural communities in NHAR, and this study provides the first attempt to determine the costs of morbidity and surgical intervention of human CE and AE cases both at the hospital and community level in this setting"
10/01/2004 - "Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001)."
07/01/2000 - "With regard to the studies' findings on cases of spinal hydatid cysts, the authors found that administration of chemotherapeutic drugs was the only statistically significant parameter (t = 3.78, p < 0.05), with the rate of chemotherapy higher in the cooperative study"
Order ALL the reference details at left...
2. Aftercare (After-Treatment)
3. Cystectomy
4. Sclerotherapy
5. Chinese Traditional Medicine (Traditional Chinese Medicine)

Best Treatments:
Research Summary Report
on Echinococcosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 85 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>